GeneDx Holdings WGS Accounts payable and other current liabilities (Note 11)
Accounts payable and other current liabilities (Note 11) at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's accounts payable and other current liabilities (note 11).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's accounts payable and other current liabilities (note 11)?
- GeneDx Holdings (WGS) reported accounts payable and other current liabilities (note 11) of $46.56M in Q1 2026.
- How has GeneDx Holdings's accounts payable and other current liabilities (note 11) changed year-over-year?
- GeneDx Holdings's accounts payable and other current liabilities (note 11) increased by 11.2% year-over-year, from $41.86M to $46.56M.
- What is the long-term trend for GeneDx Holdings's accounts payable and other current liabilities (note 11)?
- Over 5 years (2020 to 2025), GeneDx Holdings's accounts payable and other current liabilities (note 11) has grown at a 258.7% compound annual growth rate (CAGR), from $97.12K to $57.65M.